Skip to main content
. 2020 Jul 7;10:1094. doi: 10.3389/fonc.2020.01094

Figure 4.

Figure 4

The levels of LKB1, AMPK, ELAVL1, LPCAT2, and β-actin proteins. (A) Expression of these proteins in KYSE-450 cells treated with AMPK activator or LPCAT2 siRNA fragment. (B) Expression of these proteins in KYSE-450 cells treated with AMPK siRNA or angustoline. (C) Expression of these proteins in KYSE-450 cells treated with LKB1 siRNA or angustoline. (D) Densitometric quantitations for normalized proteins relative to β-actin (%) in (A). (E) Densitometric quantitations for normalized proteins relative to β-actin (%) in (B). (F) Densitometric quantitations for normalized proteins relative to β-actin (%) in (C). The data were represented as mean ± SD, *p < 0.05, compared with the control. n = 3.